Cell membrane integrity in myotonic dystrophy type 1: implications for therapy.

Autor: González-Barriga A; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands; Prosensa Therapeutics B.V., Leiden, The Netherlands., Kranzen J; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands., Croes HJ; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands., Bijl S; Prosensa Therapeutics B.V., Leiden, The Netherlands., van den Broek WJ; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands., van Kessel ID; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands., van Engelen BG; Department of Neurology, Donders Centre for Neuroscience, Radboud university medical center, Nijmegen, The Netherlands., van Deutekom JC; Prosensa Therapeutics B.V., Leiden, The Netherlands., Wieringa B; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands., Mulders SA; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands; Prosensa Therapeutics B.V., Leiden, The Netherlands., Wansink DG; Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, The Netherlands.

Publikováno v: PloS one [PLoS One] 2015 Mar 23; Vol. 10 (3), pp. e0121556. Date of Electronic Publication: 2015 Mar 23 (Print Publication: 2015).

Abnormal actomyosin assembly in proliferating and differentiating myoblasts upon expression of a cytosolic DMPK isoform.

Autor: Mulders SA; Department of Cell Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. s.mulders@ncmls.nl, van Horssen R, Gerrits L, Bennink MB, Pluk H, de Boer-van Huizen RT, Croes HJ, Wijers M, van de Loo FA, Fransen J, Wieringa B, Wansink DG

Publikováno v: Biochimica et biophysica acta [Biochim Biophys Acta] 2011 May; Vol. 1813 (5), pp. 867-77. Date of Electronic Publication: 2011 Feb 02.

Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.

Autor: Mulders SA; Department of Cell Biology, Radboud University Nijmegen Medical Centre, Nijmegen,The Netherlands., van Engelen BG, Wieringa B, Wansink DG

Publikováno v: Human molecular genetics [Hum Mol Genet] 2010 Apr 15; Vol. 19 (R1), pp. R90-7. Date of Electronic Publication: 2010 Apr 20.

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.

Autor: Mulders SA; Department of Cell Biology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., van den Broek WJ, Wheeler TM, Croes HJ, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2009 Aug 18; Vol. 106 (33), pp. 13915-20. Date of Electronic Publication: 2009 Aug 10.